Cite

HARVARD Citation

    Xiong, W. et al. (2021). RRM2 Regulates Sensitivity to Sunitinib and PD‐1 Blockade in Renal Cancer by Stabilizing ANXA1 and Activating the AKT Pathway. Advanced science. 8 (18), p. n/a. [Online]. 
  
Back to record